Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis

Peer Review reports

Original Submission
30 Jan 2019	Submitted	Original manuscript
6 May 2019	Reviewed	Reviewer Report - NORIYOSHI IRIYAMA
26 Jun 2019	Reviewed	Reviewer Report - Reviewer 2
6 Jul 2019	Author responded	Author comments - Lu Tang
Resubmission - Version 2
6 Jul 2019	Submitted	Manuscript version 2
Publishing
14 Aug 2019	Editorially accepted
28 Aug 2019	Article published	10.1186/s12885-019-6039-9

Back to article page